IFNG and myeloid sarcoma: In the peripheral blood of MS patients B cells exhibit abnormal pro-inflammatory cytokine production, which can be induced by TLR9 ligand CpG-DNA or IFNγ, and promote T cell and myeloid cell activation (157, 158).